Rockland Immunochemicals
Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 that develops, manufactures, and sells antibody-based reagents, kits, and custom antibody services to biopharma, diagnostics, emerging therapeutics, and AgBio customers globally.
- Company typePrivate
- Founded1962
- HeadquartersRoyersford, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Rockland Immunochemicals does
Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 and headquartered in Limerick, Pennsylvania, that develops, manufactures, and distributes antibody-based reagents, kits, blood products, proteins, and supporting consumables, alongside a full suite of contract research and custom manufacturing services. Its catalog spans primary and secondary antibodies, blood products, proteins and peptides, cell lines and lysates, supporting reagents, and branded product lines including ModDetect™ (oligonucleotide modification detection panels), TrueBlot® (IP-compatible secondary antibodies and kits), and AccuSignal™ (over 800 ready-to-use ELISA kits, including a recently launched E. coli HCP kit). The company's services arm covers the full discovery-to-release pipeline: custom monoclonal, polyclonal, anti-oligonucleotide and anti-idiotypic antibody production; custom recombinant antibodies; protein and antibody characterization using bio-layer interferometry; antibody modification; ADA, cell-based and immunoassay development; cell banking and virus particle manufacturing; and analytical services for gene therapy, RNA therapeutics, and host cell protein impurity detection.
The business operates a hybrid revenue model combining unit-priced catalog and bulk reagent sales (e.g., individual catalog items ranging from approximately $38 to over $1,300 per unit, with bulk supply in milligrams-to-hundreds-of-grams volumes for IVD, pharma, and biotech manufacturers) and quote-based custom services typically structured as multi-year contracts. Customers are organized across four verticals: Biopharma, Diagnostics, Emerging Therapeutics (cell, gene, and RNA oligonucleotide therapies), and AgBio. Go-to-market is sales-led, executed through the rockland.com e-commerce storefront, a worldwide distributor network, a dedicated bulk-order enterprise channel, and the 2022-acquired antibodies-online GmbH European digital marketplace, supported by a content-driven marketing strategy including a 188-resource scientific library, email, social media, and webinars. US-based R&D and manufacturing at the Limerick facility, combined with 60+ years of operating history and a portfolio of registered trademarks, form the operational and reputational backbone of the franchise.
Rockland Immunochemicals firmographics
Firmographics- Name
- Rockland Immunochemicals
- Legal name
- Rockland Immunochemicals, Inc.
- Website
- https://rockland.com
- Company type
- Private
- Founded year
- 1962
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 that develops, manufactures, and sells antibody-based reagents, kits, and custom antibody services to biopharma, diagnostics, emerging therapeutics, and AgBio customers globally.
- Ownership category
- akta.pro rank
Rockland Immunochemicals industry classification
Industry- Product category
- Life Science Reagents (Antibodies and Immunoassay Kits)
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB), IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Rockland Immunochemicals is headquartered
LocationHeadquarters
- HQ city
- Royersford
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Rockland Immunochemicals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Catalog Antibodies and Reagents: Sale of primary antibodies, secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits, and specialty panels through e-commerce platform with standard product pricing.
- Custom Antibody Production Services: Custom antibody generation including monoclonal, polyclonal, anti-oligonucleotide, and anti-idiotypic antibodies. Services include the entire process from injection to validation and shipment.
- Protein and Antibody Characterization Services: Bio-layer interferometry services, qualification and validation, and stability study services for client samples.
- Assay Development Services: ADA assay development, cell-based assay development, and immunoassay development services for therapeutic development programs.
- Cell Culture and Gene Therapy Services: Cell banking, storage, virus particle manufacturing, and analytical services for gene therapy programs.
- Bulk Orders: Large-scale procurement of catalog items from milligrams to hundreds of grams for pharmaceutical, biotech, and IVD manufacturers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog antibodies and reagents with publicly listed prices |
| Unit Pricing | Pay-as-you-go | Bulk orders for pharmaceutical and biotech manufacturers |
| Other | Multi-year contract | Custom services quote-based |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Rockland Immunochemicals product offering
Product offeringCore offering
Rockland Immunochemicals manufactures and sells a catalog of primary and secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits (including over 800 AccuSignal ELISA kits) and branded reagent lines ModDetect and TrueBlot, all produced at its US-based facilities. It also provides full-service custom antibody production (monoclonal, polyclonal, recombinant, anti-oligonucleotide, anti-idiotypic), antibody and protein characterization (bio-layer interferometry, qualification, stability), assay development (ADA, cell-based, immunoassay), antibody modification (conjugation, fragmentation, purification), cell culture and virus particle manufacturing, protein expression and purification, and analytical services supporting gene therapy and RNA therapeutics programs.
Product overview
Rockland Immunochemicals is a life science reagents company founded in 1962, offering a comprehensive portfolio of antibodies, blood products, proteins, peptides, reagents, cell lines, and kits alongside a full range of contract research and manufacturing services. The core product portfolio is organized around Primary Antibodies (monoclonal, polyclonal, recombinant, epitope-tag, RFP & GFP, loading control), Secondary Antibodies (conjugated, unconjugated, pre-adsorbed, Fab fragments), Blood Products (species-specific RBCs, serum, plasma, complement), Proteins & Peptides, Supporting Reagents, Cell Lines & Lysates, and branded product lines including ModDetect™ (oligonucleotide modification detection panels), TrueBlot® (IP-compatible detection reagents), and AccuSignal™ (800+ ELISA kits). The services arm encompasses the full discovery-to-release pipeline: Custom Antibody Production, Custom Recombinant Antibodies, Protein & Antibody Characterization (BLI, validation, stability), Antibody Modification (conjugation, fragmentation, purification), Assay Development (ADA, cell-based, immunoassay), Cell Culture Services, Protein Expression & Purification, Analytical Tools for RNA Therapeutics, Analytical Tools for Impurity Detection (HCP), and Analytical Services for Gene Therapy. Rockland also offers industry-specific solutions for AgBio, Biopharma, Diagnostics, and Emerging Therapeutics markets, with US-based manufacturing for reproducibility and minimal lot-to-lot variability.
Differentiator
Problem solved
Functional benefit
Brands
- ModDetect™: Panel of specialty reagents designed to detect nucleic acid modifications independent of sequence, format, or location.
- TrueBlot®
- AccuSignal™
Products and services
- Primary Antibodies
- Secondary Antibodies
- Blood Products
- Proteins and Peptides
- Supporting Reagents
- Cell Lines and Lysates
- ModDetect Antibody Panels
- TrueBlot IP and Western Blot Reagents
- AccuSignal ELISA Kits
- Custom Antibody Production
- Custom Recombinant Antibodies (rAbs)
- Protein and Antibody Characterization
- Antibody Modification Services
- Assay Development Services
- Cell Culture Services
- Protein Expression and Purification
- Analytical Tools for RNA Therapeutics
- Analytical Tools for Impurity Detection
- Analytical Services for Gene Therapy
Quantifiable outcome
- Over 800 AccuSignal ELISA kits available for common research targets
- +1 more outcomes
Companies that use Rockland Immunochemicals
Customer profileSegments4 records
Ideal customer profiles5 records
Rockland Immunochemicals technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Rockland Immunochemicals partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered major, core and minor.
- antibodies-online GmbHmajorRockland acquired antibodies-online GmbH, a European online antibody distributor. This acquisition expanded Rockland's digital commerce presence and distribution capabilities in the European market.
- Jefferson Institute For Bioprocessing (JIB)coreRockland partners with JIB, which offers early phase pre-clinical process development, product and technology development and evaluation, analytical, and quality control services. This collaboration expands Rockland's offering in bioprocess control strategies for cell, gene, and RNA therapies.
- Abzyme TherapeuticsminorListed as a partner on Rockland's website, indicating a collaborative relationship in the life sciences sector.
- PubGrademinorListed as a partner on Rockland's website, providing publication tracking and analytics services for scientific literature.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Rockland Immunochemicals competitors and assessment
Company assessmentDirect peers
- GenScript: GenScript operates a large custom antibody and recombinant antibody/protein services business alongside a catalog reagent offering, directly mirroring Rockland's combined custom-services + catalog model for the biopharma and academic markets.
- Abcam: Abcam (now part of Danaher/Cytiva) is one of the largest research-grade antibody manufacturers globally with a deep catalog across primary and secondary antibodies, ELISA kits, and supporting reagents. It directly competes with Rockland's catalog and bulk-order business across academia, biopharma, and IVD customers.
- Cell Signaling Technology: Cell Signaling Technology (CST) manufactures and sells highly validated antibodies, ELISA kits, and supporting reagents — directly overlapping Rockland's core catalog and biopharma analytical reagents portfolio, particularly in Western blot/immunoassay applications.
- Jackson ImmunoResearch: Jackson ImmunoResearch is a specialist manufacturer of secondary antibodies and conjugation reagents, directly comparable to Rockland's secondary antibodies, conjugated formats, and Fab fragment offerings.
- Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established direct competitor in research antibodies and supporting reagents, with a broad primary/secondary antibody catalog that overlaps heavily with Rockland's pricing-tier competing SKUs.
Emerging players
- Proteintech: Proteintech has rapidly scaled a direct-to-researcher antibody catalog with a focus on validated reagents, competing most directly with Rockland's primary antibody offering and increasingly with its supporting reagent/ELISA categories.
- Sino Biological: Sino Biological manufactures recombinant proteins, antibodies, and ELISA kits with a global catalog that increasingly competes with Rockland's protein/peptide, antibody, and bulk-order lines among biopharma and IVD customers.
Broad incumbents
- Bio-Rad Laboratories: Bio-Rad is a diversified life sciences tools incumbent whose life science research segment (including antibody reagents, ELISA kits, and Western blot products) directly competes with Rockland across academic, biopharma, and diagnostics customers.
- Bio-Techne (Novus Biologicals): Bio-Techne owns the Novus Biologicals brand — one of the largest antibody catalog competitors — and also offers ELISA kits and proteins, broadly overlapping Rockland's catalog portfolio across antibody specificity categories and validated ELISA offerings.
- Thermo Fisher Scientific (Life Sciences Solutions): Thermo Fisher's Life Sciences Solutions segment encompasses the Invitrogen, Pierce, and Thermo Scientific antibody/reagent brands. It serves as the dominant broad incumbent in reagents, ELISA kits, and supporting consumables that compete across Rockland's full catalog.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Rockland Immunochemicals social profiles
Digital presenceRockland Immunochemicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rockland Immunochemicals leadership team
Management profileNumber of profiles
Profiles2 records
Rockland Immunochemicals subsidiaries and ownership
Company hierarchySubsidiaries1 record
Rockland Immunochemicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rockland Immunochemicals M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rockland Immunochemicals
What does Rockland Immunochemicals do?
Rockland Immunochemicals manufactures and sells a catalog of primary and secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits (including over 800 AccuSignal ELISA kits) and branded reagent lines ModDetect and TrueBlot, all produced at its US-based facilities. It also provides full-service custom antibody production (monoclonal, polyclonal, recombinant, anti-oligonucleotide, anti-idiotypic), antibody and protein characterization (bio-layer interferometry, qualification, stability), assay development (ADA, cell-based, immunoassay), antibody modification (conjugation, fragmentation, purification), cell culture and virus particle manufacturing, protein expression and purification, and analytical services supporting gene therapy and RNA therapeutics programs.
Is Rockland Immunochemicals a public or private company?
Rockland Immunochemicals is a private company. It is classified as venture growth investor backed and is currently operating.
When was Rockland Immunochemicals founded?
Rockland Immunochemicals was founded in 1962. It employs 101 to 250 people.
Where is Rockland Immunochemicals based?
Rockland Immunochemicals is headquartered in Royersford, United States, in the North America region.
How does Rockland Immunochemicals make money?
Six revenue lines are on record. Catalog Antibodies and Reagents are the primary driver. The others are custom Antibody Production Services, protein and Antibody Characterization Services, assay Development Services, cell Culture and Gene Therapy Services and bulk Orders.
Who are Rockland Immunochemicals's main competitors?
Direct peers on record are GenScript, Abcam, Cell Signaling Technology, Jackson ImmunoResearch and Santa Cruz Biotechnology. Emerging players are Proteintech and Sino Biological. Broad incumbents are Bio-Rad Laboratories, Bio-Techne (Novus Biologicals) and Thermo Fisher Scientific (Life Sciences Solutions).
Does Rockland Immunochemicals have an API?
No public API is recorded for Rockland Immunochemicals.
What industry is Rockland Immunochemicals in?
Rockland Immunochemicals's product category is Life Science Reagents (Antibodies and Immunoassay Kits). Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology). Its NAICS code is 325414 and its SIC code is 2836.